FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE

Their core work

FIB-H12O is the research foundation attached to Hospital Universitario 12 de Octubre, one of Madrid's largest public teaching hospitals. It manages and funds clinical and translational biomedical research carried out by hospital-based investigators, spanning infectious disease diagnostics, pediatric and adolescent HIV care, and fundamental cell biology of organelle communication. The foundation channels hospital clinicians and their patient cohorts into European research consortia, making it a bridge between frontline clinical medicine and EU-level science.

What they specialise in

How they've shifted over time

Earlier H2020 activity (2017 onward) centred on fundamental cell biology — mitochondrial and endolysosomal biology in T cells, with links to inflammaging and cardiorenal disease through the EndoMitTalk ERC project. From 2019-2020 the focus shifted visibly toward clinical infectious disease research, joining the REACH HIV network and the DIAMONDS molecular-diagnostics consortium. The trajectory moves from bench-level organelle biology toward patient-facing diagnostics and epidemiology.

Moving toward clinical-translational infectious disease projects where hospital patient access is the key contribution, away from purely mechanistic cell biology.

How they like to work

FIB-H12O has participated only as a third party in all three projects, meaning it hosts researchers funded through partner institutions rather than holding the grant itself. The consortia are mid-to-large in size, reaching 40 distinct partners across 14 countries, and cover both basic-science ERC grants and broad clinical networks. Partners should expect to contract with the lead institution and access H12O clinicians and patient cohorts through this third-party route.

Connected to 40 consortium partners across 14 countries, with a pan-European clinical footprint extended to Russia through the REACH HIV alliance. The network mixes academic cell-biology labs with pediatric infectious disease clinical centres.

What sets them apart

Hospital 12 de Octubre is one of Spain's largest tertiary hospitals, so FIB-H12O offers something most academic partners cannot: direct access to large, diverse Madrid patient populations for clinical and diagnostic studies. Its combined presence in an ERC cell-biology grant and two clinical-health consortia shows an unusual span from fundamental immunology to bedside infectious disease research. Partners looking for a Spanish clinical site with both basic-science and pediatric/adolescent infectious disease capacity will find both under one roof.

Highlights from their portfolio

• DIAMONDS
  Large European consortium building RNA-signature diagnostics to replace guesswork in febrile illness — directly useful to diagnostics companies and clinical labs.
• EndoMitTalk
  Host institution for an ERC Starting Grant, signalling that an individual investigator there was judged internationally excellent in fundamental cell biology.
• REACH
  Rare Russia-Europe clinical alliance focused on HIV in women, children and adolescents — a politically and scientifically distinctive network.